Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Knowing when to adjust your financial plan can significantly impact your financial success. Learn key indicators for making timely adjustments.
23,637 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Weeks after elon musk called anthropic, SpaceX lands a $4 billion data center deal with Anthropic, signaling a shift ...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
President Trump’s China visit yielded no major pact, leaving investors and households awaiting clearer benefits. Anal...
Solana is slipping as broader crypto markets pull back, with traders weighing key support levels and evolving ETF flo...
As AI reshapes the job market and tuition costs rise, the debate over whether the college degree still worth the cost...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
Strategy moved 411.48 BTC worth more than $30 million to Coinbase Prime, prompting fresh debate about whether the sta...
Oil prices edge up near the mid-$90s on June 1, 2026, as traders weigh supply risks and summer demand. Brent sits aro...
U.S. companies are winning on AI adoption, pushing workers to use AI at scale while facing runaway costs and costly m...
Brookfield Corporation just bought back a substantial amount of its own stock. The move raises questions about whethe...
FIFA defends ticket prices as market-driven, but economists argue the pricing system is designed to maximize revenue ...